Efficacy of topical insulin versus normal saline in promoting granulation tissue formation and healing in diabetic foot ulcers: a prospective non-randomized interventional comparative study
DOI:
https://doi.org/10.18203/2349-2902.isj20252681Keywords:
Diabetic foot ulcer, Granulation tissue, Normal saline, Topical insulin, Wound healingAbstract
Background: Diabetic foot ulcers (DFUs) represent a severe complication of diabetes mellitus, substantially increasing the risk of morbidity, extended hospital stays and potential limb amputation. Conventional management strategies often yield suboptimal healing outcomes, necessitating exploration of novel therapies. Topical insulin has emerged as a potential adjunct due to its mitogenic, angiogenic and anti-inflammatory properties. To evaluate the efficacy of topical insulin versus normal saline in promoting granulation tissue formation and wound healing in patients with diabetic foot ulcers.
Methods: A prospective, non-randomized interventional comparative study was conducted at Dr. R.P.G.M.C. Kangra at Tanda over one year, enrolling 40 patients with Wagner grade I–II DFUs. Patients were allocated into two groups: Group A (Topical Insulin) received dressings with 30 IU regular human insulin in 30 ml normal saline, while Group B (Control) received normal saline dressings alone. Granulation tissue percentage, ulcer area and fasting blood sugar (FBS) levels were assessed at baseline, 1 week and 3 weeks.
Results: Significant improvements in fasting blood sugar (FBS) levels and ulcer area were observed within both groups. However, Group A exhibited a significantly greater increase in granulation tissue formation (from 21.44% to 73.74%) compared to Group B (from 17.46% to 56.6%) at 3 weeks (p<0.05). No significant inter-group difference was observed in ulcer area reduction within the study duration.
Conclusions: Topical insulin significantly enhances granulation tissue formation in DFUs and represents a safe, cost-effective adjunct to conventional therapy, particularly beneficial in resource-limited settings.
Metrics
References
International Diabetes Federation. IDF Diabetes Atlas. 10th ed. Brussels: International Diabetes Federation; 2021. Available from: https://diabetesatlas.org. Accessed on 21 March 2025.
Zhang P, Lu J, Jing Y, Tang S, Zhu D, Bi Y. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis. Ann Med. 2017;17;49(2):106-16. DOI: https://doi.org/10.1080/07853890.2016.1231932
Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA. 2005;293(2):217-28. DOI: https://doi.org/10.1001/jama.293.2.217
Armstrong DG, Boulton AJ, Bus SA. Diabetic foot ulcers and their recurrence. New England J Med. 2017;376(24):2367-75. DOI: https://doi.org/10.1056/NEJMra1615439
Zhang Y, Lazzarini PA, McPhail SM, van Netten JJ, Armstrong DG, Pacella RE. Global disability burdens of diabetes-related lower-extremity complications in 1990 and 2016. Diabetes Care. 2020;1;43(5):964-74. DOI: https://doi.org/10.2337/dc19-1614
Brem H, Tomic-Canic M. Cellular and molecular basis of wound healing in diabetes. J Clin Invest. 2007;117(5):1219-22. DOI: https://doi.org/10.1172/JCI32169
Falanga V. Wound healing and its impairment in the diabetic foot. Lancet. 2005;12;366(9498):1736-43. DOI: https://doi.org/10.1016/S0140-6736(05)67700-8
Game F, Jeffcoate W. How to assess the quality of clinical trials for diabetic foot ulcer therapies. Foot Diabetes. 2020;24:225-34. DOI: https://doi.org/10.1002/9781119445821.ch13
Liu Y, Petreaca M, Martins‐Green M. Cell and molecular mechanisms of insulin‐induced angiogenesis. J Cell Mol Med. 2009;13(12):4492-504. DOI: https://doi.org/10.1111/j.1582-4934.2008.00555.x
Rezvani O, Kamrani RS, Mobayen MR, Araghi A, Golchi F. Topical insulin as a novel treatment in wound healing in the animal model: a randomized controlled trial. World J Plast Surg. 2019;8(2):200–6.
Tiwari VK, Mishra B, Yadav PK, Rastogi A, Gupta SK. Effect of topical application of insulin on wound healing. J Wound Care. 2012;21(12):577–83.
Boulton AJ, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J. The global burden of diabetic foot disease. Lancet. 2005;366(9498):1719-24. DOI: https://doi.org/10.1016/S0140-6736(05)67698-2
Edmonds M, Foster A. The use of antibiotics in the diabetic foot. The American journal of surgery. 2004;1;187(5): S25-8. DOI: https://doi.org/10.1016/S0002-9610(03)00300-3
Wang J, Xu J. Effects of topical insulin on wound healing: a review of animal and human evidences. Diabetes, metabolic syndrome and obesity. 2020;13:719-27. DOI: https://doi.org/10.2147/DMSO.S237294
Lima MH, Caricilli AM, de Abreu LL, Araujo EP, Pelegrinelli FF, Thirone AC, et al. Topical insulin accelerates wound healing in diabetes by enhancing the AKT and ERK pathways: a double-blind placebo-controlled clinical trial. PloS one. 2012;7(5):36974. DOI: https://doi.org/10.1371/journal.pone.0036974
Greenhalgh DG. Wound healing and diabetes mellitus. Clinics in plastic surgery. 2003;30(1):37-45. DOI: https://doi.org/10.1016/S0094-1298(02)00066-4
Werdin F, Tenenhaus M, Rennekampff HO. Chronic wound care. Lancet. 2008;372(9653):1860-2. DOI: https://doi.org/10.1016/S0140-6736(08)61793-6
Martins-Mendes D, Monteiro-Soares M, Boyko EJ, Ribeiro M, Barata P, Lima J, et al. The independent contribution of diabetic foot ulcer on lower extremity amputation and mortality risk. J Diab Compl. 2014;28(5):632-8. DOI: https://doi.org/10.1016/j.jdiacomp.2014.04.011
Souza Leal L, Carvalho E, Tavares Pereira M, Xavier S, Càssia T, Rocha J, et al. Topical insulin therapy for healing of chronic skin ulcers. Diabetes Care. 2002;25(2):233–8.
Downloads
Published
How to Cite
Issue
Section
